Collegium Pharmaceutical Statistics
Total Valuation
COLL has a market cap or net worth of $1.17 billion. The enterprise value is $1.68 billion.
| Market Cap | 1.17B |
| Enterprise Value | 1.68B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COLL has 32.43 million shares outstanding. The number of shares has increased by 8.45% in one year.
| Current Share Class | 32.43M |
| Shares Outstanding | 32.43M |
| Shares Change (YoY) | +8.45% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 124.20% |
| Float | 32.05M |
Valuation Ratios
The trailing PE ratio is 22.00.
| PE Ratio | 22.00 |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | 1.32 |
| PB Ratio | 3.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.55 |
| P/OCF Ratio | 3.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.95, with an EV/FCF ratio of 5.09.
| EV / Earnings | 22.39 |
| EV / Sales | 2.11 |
| EV / EBITDA | 3.95 |
| EV / EBIT | 8.41 |
| EV / FCF | 5.09 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 2.98.
| Current Ratio | 1.71 |
| Quick Ratio | 1.50 |
| Debt / Equity | 2.98 |
| Debt / EBITDA | 2.15 |
| Debt / FCF | 2.82 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 27.41% and return on invested capital (ROIC) is 16.54%.
| Return on Equity (ROE) | 27.41% |
| Return on Assets (ROA) | 7.60% |
| Return on Invested Capital (ROIC) | 16.54% |
| Return on Capital Employed (ROCE) | 16.40% |
| Weighted Average Cost of Capital (WACC) | 7.17% |
| Revenue Per Employee | $1.88M |
| Profits Per Employee | $177,184 |
| Employee Count | 423 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, COLL has paid $33.29 million in taxes.
| Income Tax | 33.29M |
| Effective Tax Rate | 30.75% |
Stock Price Statistics
The stock price has increased by +13.57% in the last 52 weeks. The beta is 0.73, so COLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +13.57% |
| 50-Day Moving Average | 34.80 |
| 200-Day Moving Average | 39.23 |
| Relative Strength Index (RSI) | 54.23 |
| Average Volume (20 Days) | 495,657 |
Short Selling Information
The latest short interest is 5.47 million, so 16.85% of the outstanding shares have been sold short.
| Short Interest | 5.47M |
| Short Previous Month | 5.33M |
| Short % of Shares Out | 16.85% |
| Short % of Float | 17.06% |
| Short Ratio (days to cover) | 11.92 |
Income Statement
In the last 12 months, COLL had revenue of $796.33 million and earned $74.95 million in profits. Earnings per share was $1.64.
| Revenue | 796.33M |
| Gross Profit | 710.08M |
| Operating Income | 199.61M |
| Pretax Income | 108.24M |
| Net Income | 74.95M |
| EBITDA | 425.05M |
| EBIT | 199.61M |
| Earnings Per Share (EPS) | $1.64 |
Balance Sheet
The company has $421.75 million in cash and $929.69 million in debt, with a net cash position of -$507.94 million or -$15.66 per share.
| Cash & Cash Equivalents | 421.75M |
| Total Debt | 929.69M |
| Net Cash | -507.94M |
| Net Cash Per Share | -$15.66 |
| Equity (Book Value) | 312.42M |
| Book Value Per Share | 9.64 |
| Working Capital | 310.70M |
Cash Flow
In the last 12 months, operating cash flow was $331.04 million and capital expenditures -$1.21 million, giving a free cash flow of $329.83 million.
| Operating Cash Flow | 331.04M |
| Capital Expenditures | -1.21M |
| Depreciation & Amortization | 225.45M |
| Net Borrowing | -61.49M |
| Free Cash Flow | 329.83M |
| FCF Per Share | $10.17 |
Margins
Gross margin is 89.17%, with operating and profit margins of 25.07% and 9.41%.
| Gross Margin | 89.17% |
| Operating Margin | 25.07% |
| Pretax Margin | 13.59% |
| Profit Margin | 9.41% |
| EBITDA Margin | 53.38% |
| EBIT Margin | 25.07% |
| FCF Margin | 41.42% |
Dividends & Yields
COLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.45% |
| Shareholder Yield | -8.45% |
| Earnings Yield | 6.40% |
| FCF Yield | 28.19% |
Analyst Forecast
The average price target for COLL is $53.60, which is 48.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $53.60 |
| Price Target Difference | 48.56% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 2.23% |
| EPS Growth Forecast (3Y) | -6.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
COLL has an Altman Z-Score of 1.56 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.56 |
| Piotroski F-Score | 8 |